Pharmaceutical giant Bayer is bringing a cannabis-based spray onto the market in Britain and will likely distribute it soon throughout other countries.

Germany-based Bayer signed an agreement with UK-based GW Pharmaceuticals for exclusive distribution of the cannabis-based medication, called Sativex.

Sprayed into the mouth, Sativex provides pain relief for people with multiple sclerosis and neuropathy, and may be developed into a pain-reliever for people with cancer.

More here.